
Home | GSK
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact …
GSK plc - Wikipedia
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3][4] It was …
GSK plc (GSK) Stock Price, News, Quote & History - Yahoo Finance
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
Is GSK plc (GSK) the Most Undervalued Healthcare Stock to Buy …
3 天之前 · We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc …
Company | GSK
We unite science, technology and talent to get ahead of disease together. Ahead Together. Innovation to prevent and treat disease is at the heart of everything we do. We aim to …
History and heritage - GSK
The GSK of today. GSK plc underwent a transformation in 2022, separating its consumer healthcare business to establish Haleon plc as an independent listed company. This marked a …
GSK Investors Have Opportunity to Lead GSK plc Class Action …
1 天前 · GSK Investors Have Opportunity to Lead GSK plc Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! PRESS RELEASE ACCESS Newswire Apr. 3, …
Company | GSK US
GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore …
GSK plc (GSK) Company Profile & Description - Stock Analysis
2025年3月21日 · GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat …
50 Facts About GSK Plc
2025年3月9日 · GSK plc, a pharmaceutical giant with roots dating back to 1715, has a global presence in over 75 countries, employing around 70,000 people and investing £6.2 billion in …